ALLUMINOX PALETTE
LIVE

Serial Number

97589806

Owner

Rakuten Medical, Inc.

Attorney

Gina Durham, Esq.

Filing Date

Sep 13, 2022

Add to watchlist:

No watchlists yet
View on USPTO

ALLUMINOX PALETTE Trademark

Serial Number: 97589806

ALLUMINOX PALETTE is a trademark filed by Rakuten Medical, Inc. on September 13, 2022. The trademark is classified under Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

Rakuten Medical, Inc.

6885 Flanders Drive, Suite 100
San Diego, CA 92121

Entity Type: 03

Trademark Details

Filing Date

September 13, 2022

Registration Date

Not Registered

Published for Opposition

November 7, 2023

Goods & Services

Scientific, biological, and medical research; conducting clinical trials for others for the purpose of advancing knowledge and developing new approaches; providing prescription scientific drug research information by means of providing links to third party websites relating to cancer drugs; Providing temporary use of on-line non-downloadable software for tracking and storing personal information about the symptoms, side effects, treatment of and experience with an individual's cancer, logging daily actions and results of activity and cognitive tests, and sharing results based on such information; all of the foregoing in the field of cancer and pre-cancerous prevention based on photoimmunotherapy, and cancer and pre-cancerous treatment based on photoimmunotherapy; and none of the foregoing in connection with diagnostics, genetics, and genetic sequencing

Educational services, namely, providing classes, seminars, and lectures, all in the field of treatment of cancer; providing training in the oncology field; all of the foregoing in the field of cancer and pre-cancerous prevention based on photoimmunotherapy, and cancer and pre-cancerous treatment based on photoimmunotherapy; and none of the foregoing in connection with diagnostics, genetics, and genetic sequencing

Providing medical information in the field of health care, medical conditions, medicine and pharmaceuticals; Providing medical information on pharmaceuticals and oncology platforms; Providing medical and patient support information in relation to the treatment of cancer; counseling services, namely, medical counseling for patients diagnosed with cancer related to prevention and treatment; providing medical information services in the field of treating cancer; Providing online information services, namely, prescription drug medical information; Providing information in the field of medicine; providing medical information regarding medical conditions and diseases and providing information relating to the health effects of pharmaceuticals; Providing an Internet website featuring medical information and articles about cancer, cancer recovery, cancer treatment, and post-cancer treatment care and survival; providing an online searchable database featuring articles and medical information about cancer, cancer recovery, cancer treatment, and post-cancer treatment care and survival; providing healthcare information regarding cancer drugs and cancer treatment; all of the foregoing in the field of cancer and pre-cancerous prevention based on photoimmunotherapy, and cancer and pre-cancerous treatment based on photoimmunotherapy; and none of the foregoing in connection with diagnostics, genetics, and genetic sequencing

Filing History

SOU TEAS EXTENSION RECEIVED
Jun 8, 2026 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 4, 2025 EXRA
SOU EXTENSION 4 GRANTED
Nov 3, 2025 EX4G
SOU EXTENSION 4 FILED
Nov 3, 2025 EXT4
SOU TEAS EXTENSION RECEIVED
Nov 3, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 26, 2025 EXRA
SOU EXTENSION 3 GRANTED
Jun 25, 2025 EX3G
SOU EXTENSION 3 FILED
Jun 25, 2025 EXT3
SOU TEAS EXTENSION RECEIVED
Jun 25, 2025 EEXT
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 16, 2025 TCCA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Apr 16, 2025 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Apr 16, 2025 COAR
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 3, 2025 EXRA
SOU EXTENSION 2 GRANTED
Dec 17, 2024 EX2G
SOU EXTENSION 2 FILED
Dec 16, 2024 EXT2
SOU TEAS EXTENSION RECEIVED
Dec 16, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 14, 2024 EXRA
SOU EXTENSION 1 GRANTED
Jun 14, 2024 EX1G
SOU EXTENSION 1 FILED
Jun 14, 2024 EXT1
SOU TEAS EXTENSION RECEIVED
Jun 14, 2024 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jan 2, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 7, 2023 NPUB
PUBLISHED FOR OPPOSITION
Nov 7, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 18, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 2, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 30, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 29, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 29, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 30, 2023 GNRN
NON-FINAL ACTION E-MAILED
Jun 30, 2023 GNRT
NON-FINAL ACTION WRITTEN
Jun 30, 2023 CNRT
ASSIGNED TO EXAMINER
Jun 26, 2023 DOCK
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Nov 1, 2022 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 1, 2022 TCCA
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Nov 1, 2022 COAR
NOTICE OF DESIGN SEARCH CODE E-MAILED
Sep 29, 2022 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 28, 2022 NWOS
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Sep 26, 2022 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 26, 2022 TCCA
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Sep 26, 2022 COAR
NEW APPLICATION ENTERED
Sep 16, 2022 NWAP